The Healthcare & MedTech sector is all about innovation in a regulated environment and transactions that do justice to both sides.
The healthcare sector is experiencing an ongoing wave of consolidation: medical technology companies, digital health platforms, laboratory service providers and specialised care facilities are increasingly the subject of M&A processes. ROHDE BAIER advises founders, investors and strategic buyers on transactions across the entire healthcare spectrum, from early-stage financing of innovative medtech companies to the exit of established healthcare providers. In doing so, we take into account the sector-specific particularities: regulatory authorisations, reimbursement systems, medical professional law structures and data protection requirements in the healthcare sector.
Our clients are entrepreneurs in the healthcare sector, private equity investors with a healthcare focus and corporate venture units of pharmaceutical and medical technology groups. We support them from the structuring of shareholdings to the negotiation of complex guarantee and indemnification catalogues and the implementation of regulatory sensitive transactions under company law.
ROHDE BAIER understands the interface between entrepreneurial dynamics and the regulatory framework and creates transaction structures that fulfil both requirements.
